Ticker
ESPRCompany Name
ESPERION THERAPEUTICS INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NASDAQDate | Total Assets | Cash and Equivalents | Core Assets | Goodwill and Intangibles |
---|---|---|---|---|
6/30/2025 | $ 347.08M | $ 86.06M | $ 260.97M | $ 56K |
3/31/2025 | $ 324.03M | $ 114.63M | $ 209.34M | $ 56K |
12/31/2024 | $ 343.82M | $ 144.76M | $ 199M | $ 56K |
9/30/2024 | $ 314.11M | $ 144.72M | $ 169.34M | $ 56K |
6/30/2024 | $ 352.32M | $ 189.3M | $ 162.96M | $ 56K |
3/31/2024 | $ 373.06M | $ 226.61M | $ 146.4M | $ 56K |
12/31/2023 | $ 205.8M | $ 82.25M | $ 123.49M | $ 56K |
9/30/2023 | $ 221.31M | $ 114.83M | $ 106.42M | $ 56K |
6/30/2023 | $ 234.63M | $ 138.47M | $ 96.1M | $ 56K |
3/31/2023 | $ 251.82M | $ 144.91M | $ 106.85M | $ 56K |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Assets - Intangibles - CashnEq
(=) Core Assets
Core Assets for ESPERION THERAPEUTICS INC is calculated as follows: Assets [ $ 250.97M ] - Intangibles [ $ 0 ] - CashnEq [ $ 215.75M ]
(=) Core Assets [ $ 35.22M ]
Minimum
Sep 30, 2020
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 3.42K |
---|---|
min | $ 0 |
max | $ 4.36B |
average | $ 798.38M |
median | $ 287.61M |
std | $ 1.05B |